AWT Labels and Packaging has acquired US-based Citation Clinical Labeling Systems, which provides clinical trial labels for pharmaceutical and biotechnology companies, for an undisclosed sum.
Following the acquisition, Citation Clinical Labeling business, which will be owned by AWT and management, will now operate as Citation Healthcare Labels.
Citation president Richard Bolnick and chief operating officer Frederick Youngs will continue in their respective roles as well as will become shareholders of AWT.
The company also offers clinical trial labels for clinical research organisations and clinical packagers. It provides product quality, project management, customer service and speed to market services for pharmaceutical customers.
Citation currently operates from a single pharmaceutical and medical grade facility in Hauppauge, New York and employs approximately 100 employees.
Bolnick said: “Citation looks forward to the next chapter of growth by joining the AWT organisation.
“Citation and AWT share many of the same philosophies including providing our customers with a world-class experience, a commitment to healthcare labelling and quality systems, the development of our employees and continually investing in state-of-the-art equipment.
“We believe the best is yet to come for our customers as they will benefit from additional facilities, personnel and resources of the combined businesses.”
The deal strengthens AWT’s presence in healthcare labelling market globally, and enable it to benefit from the growth opportunities in the clinical trial label markets.
As part of the deal, Citation customers can now access AWT’s resources and investments in print and production technologies and its healthcare labelling plant in Minneapolis.